November 4, 2026 · Endoscopy · DOI: 10.1055/a-2997-9672

Declining Cost-Effectiveness of Gastric Cancer Screening Over a Decade: A Cohort Modelling Study.

Listen to this summary

This study asks whether Korea's National Cancer Screening Program for gastric cancer remained cost-effective as disease incidence, costs, and population risk changed between 2012 and 2022. Using two structurally identical state-transition models parameterized with each period's conditions, the authors found that the incremental cost-utility ratio rose from KRW 9.62 million/QALY to KRW 48.62 million/QALY, pushing net monetary benefit near zero by 2025 prices at a KRW 50 million/QALY threshold. The decline was driven mainly by a shift in screen-detected findings toward lower-risk non-adenomatous lesions and higher costs, and it was markedly worse for women (KRW 84.37 million/QALY) than for men (KRW 28.20 million/QALY), supporting periodic reassessment and differentiated screening strategies.

Kyung-Ae Nam, Donghoon Kang, Jongin Lee, Hwa-Young Lee, Ilsoo Kim, Yu Kyung Cho, Sun-Kyeong Park, Jae Myung Park

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play